Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| BridgeBio Pharma, Inc.(BBIO) | 4,589,611 | 3,089,611 | -1,500,000 | $341.83M | $203.30M | 67.92% | -$138.54M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 1,316,806 | 1,316,806 | 0 | $28.79M | $24.76M | 8.27% | -$4.03M |
| COMPASS Pathways plcADS(CMPS) | 1,432,336 | 1,732,336 | +300,000 | $20.27M | $21.55M | 7.20% | +$1.28M |
| Monte Rosa Therapeutics Inc | 1,555,664 | 1,555,664 | 0 | $37.65M | $18.56M | 6.20% | -$19.09M |
| Bicara Therapeutics Inc | 568,919 | 548,919 | -20,000 | $16.89M | $10.22M | 3.41% | -$6.68M |
| UroGen Pharma Ltd.(URGN) | 108,000 | 108,000 | 0 | $3.97M | $4.39M | 1.47% | +$413.6K |
| Bridgebio Oncology Therapeut | 1,018,018 | 1,018,018 | 0 | $7.76M | $4.14M | 1.38% | -$3.62M |
| Eupraxia Pharmaceuticals Inc | 325,000 | 325,000 | 0 | $2.15M | $2.96M | 0.99% | +$809.3K |
| Biomea Fusion Inc | 2,048,757 | 2,048,757 | 0 | $3.01M | $2.74M | 0.92% | -$268.8K |
| Aclaris Therapeutics Inc | 434,455 | 434,455 | 0 | $2.30M | $2.29M | 0.76% | -$13.0K |
| Scholar Rock Holding Corporation(SRRK) | 77,031 | 42,031 | -35,000 | $4.24M | $2.03M | 0.68% | -$2.21M |
| Vtv Therapeutics IncCL A | 50,000 | 58,775 | +8,775 | $1.88M | $1.81M | 0.61% | -$69.9K |
| Marker Therapeutics Inc | 325,370 | 325,370 | 0 | $478.3K | $348.1K | 0.12% | -$130.1K |
| Onkure Therapeutics IncCL A | 88,607 | 88,607 | 0 | $404.0K | $241.5K | 0.08% | -$162.6K |